Systematic Review and Meta-Analysis: Preoperative Vedolizumab and Postoperative Complications in Patients with IBD

医学 维多利祖马布 荟萃分析 内科学 梅德林 普通外科 外科 溃疡性结肠炎 疾病 法学 政治学
作者
Zain Moosvi,Jacqueline Duong,Matthew L. Bechtold,Douglas L. Nguyen
出处
期刊:Southern Medical Journal [Lippincott Williams & Wilkins]
卷期号:114 (2): 98-105 被引量:8
标识
DOI:10.14423/smj.0000000000001214
摘要

The effect of vedolizumab on postoperative outcomes in patients with inflammatory bowel disease (IBD) remains unclear. We aimed to determine the relation between preoperative vedolizumab and early postoperative complications in patients with IBD undergoing abdominal surgery.A search of databases and abstracts from gastroenterology conferences was performed. Primary outcomes included overall and infectious postoperative complication rates as well as surgical site infections. Studies that compared Crohn disease, ulcerative colitis, or patients with IBD-undefined with preoperative vedolizumab treatment undergoing abdominal surgery with controls with preoperative antitumor necrosis factor-α (anti-TNF-α) treatment or no preoperative biologic treatment were included. A meta-analysis was completed using the Mantel-Haenszel and DerSimonian and Laird models.Six studies totaling 1201 patients were included; 281 patients were treated preoperatively with vedolizumab, 327 patients were treated preoperatively with anti-TNF-α agents, and 593 patients were not treated preoperatively with any biologics. There was no significant difference in overall complications (odds ratio [OR] 1.04, 95% confidence interval [CI] 0.48-2.24, P = 0.92, I2 =77%) between the vedolizumab and no-biologic groups. There also was no significant difference in infectious complications (OR 1.00, 95% CI 0.37-2.69, P = 1.00, I2 = 78%), which persisted after sensitivity analysis (OR 0.71, 95% CI 0.31-1.60, P = 0.41, I2 = 46%). Furthermore, there was no significant difference in overall complications (OR 0.77, 95% CI 0.24-2.46, P = 0.66, I2 = 85%) and infectious complications (OR 0.89, 95% CI 0.20-3.94, P = 0.87, I2 = 86%) between the vedolizumab and anti-TNF-α groups. After sensitivity analysis, differences in overall and infectious complications remained insignificant (OR 0.54 and 0.50, 95% CI 0.24-1.17 and 0.22-1.15, P = 0.12 and 0.10, I2 = 39% and 18%, respectively). Vedolizumab was also not associated with a significant increase in surgical site infections compared with the no-biologic (OR 1.45, 95% CI 0.33-6.32, P = 0.62, I2 = 75%) and anti-TNF (OR 1.30, 95% CI 0.22-7.60, P = 0.77, I2 = 81%) groups.Preoperative treatment with vedolizumab in patients with IBD undergoing abdominal surgery is not associated with increases in overall or infectious postoperative complications compared with preoperative anti-TNF-α treatment and no preoperative biologic treatment. Large, prospective studies are needed to further assess the impact of preoperative vedolizumab treatment on postoperative complications, particularly with respect to IBD subtype.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
15735802374发布了新的文献求助10
刚刚
无极微光的应助被小鱼采纳,获得20
1秒前
123的应助被suhang2024采纳,获得10
1秒前
SUNstp发布了新的文献求助10
1秒前
wenhan发布了新的文献求助20
2秒前
2秒前
RiCh发布了新的文献求助10
2秒前
酷酷平凡完成签到,获得积分10
3秒前
一行发布了新的文献求助10
3秒前
221008zn发布了新的文献求助10
3秒前
3秒前
4秒前
我是老大的应助被悦耳白山采纳,获得10
4秒前
jy完成签到,获得积分10
5秒前
5秒前
沈如晤完成签到 ,获得积分10
5秒前
Dominic发布了新的文献求助10
5秒前
贾炎彬完成签到,获得积分10
6秒前
默默芯的应助被zcl采纳,获得20
6秒前
orixero的应助被尼奥采纳,获得10
7秒前
zfg完成签到,获得积分10
7秒前
晚风发布了新的文献求助10
7秒前
大个的应助被e个汉堡包采纳,获得10
8秒前
8秒前
lou完成签到,获得积分10
8秒前
唠叨的机器猫完成签到,获得积分10
8秒前
9秒前
SYF发布了新的文献求助10
9秒前
酸奶刨冰完成签到,获得积分10
11秒前
Monarch完成签到,获得积分10
11秒前
12秒前
鱼鱼完成签到 ,获得积分10
12秒前
青梧完成签到,获得积分10
13秒前
裴瑞志完成签到,获得积分10
13秒前
归宁发布了新的文献求助10
14秒前
Sherlock完成签到,获得积分10
16秒前
荔枝味完成签到,获得积分20
16秒前
感动如音完成签到 ,获得积分10
17秒前
不想看文献完成签到 ,获得积分10
17秒前
Maestro_S的应助被晚风采纳,获得10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8172327
求助须知:如何正确求助?哪些是违规求助? 9564990
关于积分的说明 21777687
捐赠科研通 7763968
什么是DOI,文献DOI怎么找? 3431223
关于科研通互助平台的介绍 2555098
邀请新用户注册赠送积分活动 2476246